LivaNova (NASDAQ:LIVN) Given Buy Rating at Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of LivaNova (NASDAQ:LIVN) in a report issued on Tuesday morning,Benzinga reports. Needham & Company LLC currently has a $75.00 price target on the stock.

Several other equities research analysts have also commented on the stock. Baird R W upgraded shares of LivaNova from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, September 17th. Stifel Nicolaus raised their price objective on shares of LivaNova from $70.00 to $72.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th. StockNews.com raised LivaNova from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 8th. The Goldman Sachs Group began coverage on LivaNova in a research report on Friday, October 4th. They set a “buy” rating and a $65.00 price target for the company. Finally, Mizuho reduced their price objective on LivaNova from $80.00 to $70.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a hold rating, five have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $69.17.

LivaNova Stock Performance

Shares of LIVN stock opened at $53.00 on Tuesday. The stock has a fifty day moving average price of $51.40 and a 200 day moving average price of $53.00. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37. The stock has a market cap of $2.88 billion, a PE ratio of 126.52 and a beta of 1.01. LivaNova has a 1 year low of $42.75 and a 1 year high of $64.47.

Institutional Investors Weigh In On LivaNova

A number of hedge funds and other institutional investors have recently made changes to their positions in LIVN. Fifth Third Bancorp boosted its stake in LivaNova by 97.1% in the 2nd quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock worth $37,000 after buying an additional 332 shares during the last quarter. Hexagon Capital Partners LLC boosted its position in shares of LivaNova by 117.8% in the second quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock worth $37,000 after acquiring an additional 370 shares during the last quarter. Lazard Asset Management LLC purchased a new stake in LivaNova in the first quarter valued at approximately $84,000. Canada Pension Plan Investment Board purchased a new position in LivaNova during the second quarter worth approximately $88,000. Finally, Acadian Asset Management LLC purchased a new position in LivaNova during the first quarter worth approximately $94,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.